Parse Biosciences is a company with the mission of accelerating progress in human health and scientific research. At the core of the company is a pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
01/26/21	$7,000,000	Series A	Bioeconomy Capital	undisclosed
02/15/22	$41,500,000	Series B	Bioeconomy Capital Janus Henderson Investors Logos Capital Marshall Wace Soleus Capital	undisclosed
12/14/23	$50,000,000	Series C	Bioeconomy Capital Janus Henderson Investors Marshall Wace Sahsen Ventures Saras Capital Soleus Capital	undisclosed